Bill Search

  • Introduced
    Feb 24, 2021
  • Passed Senate
    Mar 11, 2021
  • Passed House
    Apr 06, 2021
  • Signed into Law
    Apr 13, 2021
SB 387
Arkansas Senate Bill
TO AUTHORIZE OFF-LABEL USE OF DRUG TREATMENTS TO TREAT MEDICAID BENEFICIARIES WITH PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME AND PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH STREPTOCOCCAL INFECTION.
Last Action
Senate • Apr 13, 2021: Notification that SB387 is now Act 637
Latest bill text

Official Summary/Bill Text

Comments on Bill

Tweets

Whip Lists

Do you support this bill?
Yay Nay
Sponsors:
Actions
  • Apr 13, 2021 | Senate
    • Notification that SB387 is now Act 637
  • Apr 07, 2021 | Senate
    • Reported correctly enrolled and ordered delivered to the Governor.
    • DELIVERED TO GOVERNOR.
  • Apr 06, 2021 | Senate
    • Returned from the House as passed.
    • ORDERED ENROLLED
  • Apr 06, 2021 | House
    • Read the third time and passed and ordered transmitted to the Senate.
    • Returned To the Senate as passed.
  • Apr 01, 2021 | House
    • Returned by the Committee Do Pass
  • Mar 11, 2021 | House
    • RECEIVED FROM THE SENATE
    • Read the first time, rules suspended, read the second time and referred to the Committee on PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE- HOUSE
  • Mar 11, 2021 | Senate
    • Read the third time and passed.
    • Ordered immediately transmitted to the House.
  • Mar 10, 2021 | Senate
    • Returned by the Committee, with the recommendation that it Do Pass
  • Mar 09, 2021 | Senate
    • Withdrawn from Committee for purpose of amendment # 1
    • Amendment # 1 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
    • REPORTED CORRECTLY ENGROSSED
    • Re-referred to PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE - SENATE
  • Feb 24, 2021 | Senate
    • Filed
    • Read first time, rules suspended, read second time, referred to PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE - SENATE
Documents